Search Results - "KIRSCHNER, Janbernd"
-
1
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
Published in European journal of epidemiology (01-07-2020)“…Several studies indicate that prognosis for survival in Duchenne muscular dystrophy (DMD) has improved in recent decades. However, published evidence is…”
Get full text
Journal Article -
2
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care
Published in Journal of neuromuscular diseases (01-01-2020)“…Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in SMN1 and results in the loss of motor neurons and progressive muscle weakness. The…”
Get more information
Journal Article -
3
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Published in Neuromuscular disorders : NMD (01-11-2019)“…•NURTURE is an ongoing study of nusinersen started in a presymptomatic stage of SMA.•All infants were ≥25 months old, and alive without permanent…”
Get full text
Journal Article -
4
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Published in Neuromuscular disorders : NMD (01-02-2018)“…•We report an update on standards of care recommendations for spinal muscular atrophy.•The paper provides a review of the recent literature.•Expert opinion is…”
Get full text
Journal Article -
5
Gene Therapy for Monogenic Inherited Disorders: Opportunities and Challenges
Published in Deutsches Ärzteblatt international (21-12-2020)Get full text
Journal Article -
6
Duchenne muscular dystrophy and caregiver burden: a systematic review
Published in Developmental medicine and child neurology (01-10-2018)“…Aim To conduct a systematic literature review of caregiver burden in Duchenne muscular dystrophy (DMD). Method We searched Embase, Web of Science, and PubMed…”
Get full text
Journal Article -
7
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
Published in Orphanet journal of rare diseases (29-07-2020)“…Expanded access programs (EAPs) allow patients with serious, life-threatening conditions access to drugs prior to their formal approval. Despite the possible…”
Get full text
Journal Article -
8
A multi-source approach to determine SMA incidence and research ready population
Published in Journal of neurology (01-07-2017)“…In spinal muscular atrophy (SMA), degeneration of motor neurons causes progressive muscular weakness, which is caused by homozygous deletion of the SMN1 gene…”
Get full text
Journal Article -
9
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Published in Nature (London) (28-03-2013)“…Algorithms designed to identify canonical yeast prions predict that around 250 human proteins, including several RNA-binding proteins associated with…”
Get full text
Journal Article -
10
Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies
Published in JAMA : the journal of the American Medical Association (02-07-2014)“…IMPORTANCE: Mitochondrial disorders have emerged as a common cause of inherited disease, but their diagnosis remains challenging. Multiple respiratory chain…”
Get full text
Journal Article -
11
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
Published in Orphanet journal of rare diseases (21-01-2019)“…Survival and quality of life for patients affected by spinal muscular atrophy (SMA) are thought to have improved over the last decade due to changes in care…”
Get full text
Journal Article -
12
JEWELFISH: 24-month safety and pharmacodynamic data in non-treatment- naïve patients with spinal muscular atrophy (SMA)
Published in Journal of neurology, neurosurgery and psychiatry (28-11-2023)“…Risdiplam (EVRYSDI®) is an oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifier approved by the EMA and MHRA for the treatment of patients aged ≥2…”
Get full text
Journal Article -
13
Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study
Published in Journal of neuromuscular diseases (01-01-2019)“…Spinal muscular atrophy (SMA) is a progressive autosomal recessive motor neuron disease caused by loss of the SMN1 gene. Based on randomized clinical trials in…”
Get more information
Journal Article -
14
ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia
Published in Journal of allergy and clinical immunology (01-12-2009)“…Background Defects in the development or activation of T cells result in immunodeficiency associated with severe infections early in life. T-cell activation…”
Get full text
Journal Article -
15
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial
Published in Lancet neurology (01-07-2017)“…Summary Background Spinal muscular atrophy (SMA) is a progressive motor neuron disease causing loss of motor function and reduced life expectancy, for which…”
Get full text
Journal Article -
16
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study
Published in Muscle & nerve (01-08-2023)“…Introduction/Aims NURTURE (NCT02386553) is an open‐label study of nusinersen in children (two SMN2 copies, n = 15; three SMN2 copies, n = 10) who initiated…”
Get full text
Journal Article -
17
Lack of the Mitochondrial Protein Acylglycerol Kinase Causes Sengers Syndrome
Published in American journal of human genetics (10-02-2012)“…Exome sequencing of an individual with congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, and lactic acidosis, all typical symptoms of…”
Get full text
Journal Article -
18
De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany
Published in Orphanet journal of rare diseases (24-06-2019)“…Estimation of incidence in rare diseases is often challenging due to unspecific and incomplete coding and recording systems. Patient- and health care…”
Get full text
Journal Article -
19
Hereditary neuralgic amyotrophy in childhood caused by duplication within the SEPT9 gene: A family study
Published in Cytoskeleton (Hoboken, N.J.) (01-01-2019)“…Hereditary neuralgic amyotrophy (HNA) is an autosomal dominant disorder associated with episodic, recurrent, and painful neuropathies affecting the nerves of…”
Get full text
Journal Article -
20
Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant
Published in European journal of human genetics : EJHG (01-03-2020)“…Congenital myasthenic syndromes (CMS) are a clinically and genetically heterogeneous group of disorders caused by mutations which lead to impaired…”
Get full text
Journal Article